Pathophysiological changes after lipopolysaccharide-induced acute inflammation in a type 2 diabetic rat model versus...

Area of Science:

• Endocrinology
• Pathophysiology
• Critical Care Medicine

Background:

• Acute hyperglycemia is a common complication in critically ill patients.
• The role of pre-existing diabetes in modulating the response to critical illness and hyperglycemia remains unclear.

Purpose of the Study:

• To investigate the potential protective mechanisms of pre-existing type 2 diabetes in the context of acute hyperglycemia during critical illness.
• To compare the pathophysiological responses to sepsis-induced hyperglycemia between diabetic and non-diabetic rats.

Main Methods:

• Lipopolysaccharide (LPS)-induced acute infection model in type 2 diabetic rats (GK rats) and normal controls (Wistar rats).
• Assessment of blood glucose variability, inflammatory markers (TNF-α, IL-6, IL-10), oxidative stress markers (MDA, T-AOC), and IκB-α protein levels.

Main Results:

• Diabetic rats exhibited less severe symptoms and lower blood glucose variability post-LPS injection compared to controls.
• GK rats showed a blunted pro-inflammatory response (lower TNF-α, IL-6) and an elevated anti-inflammatory response (higher IL-10) compared to Wistar rats.
• Oxidative stress markers indicated increased oxidative stress in both groups, but with differential responses in inflammatory pathway regulation.

Conclusions:

• Pre-existing diabetes is associated with adaptive cellular changes that may be protective against acute hyperglycemia-mediated damage during sepsis.
• Chronic hyperglycemia may mitigate the adverse effects of acute hyperglycemia in sepsis by reducing glucose variability and modulating inflammatory and anti-inflammatory responses.